Intended for US residents only
Watch to learn why screening for alpha-1 is important. Approximately 90% of patients with alpha-1, also known as genetic COPD, are estimated to be undiagnosed.
This website is intended for healthcare professionals only
You are now leaving AlphaID.com
The link you clicked directs to a website for a prescribed therapy for severe for alpha1-antitrypsin (AAT) deficiency.
Do you wish to continue?